MariMed Showcasing Cannabis Opportunity at Inves

MariMed Showcasing Cannabis Opportunity at Investment Conferences

March 05, 2019 08:39 ET | Source: MariMed Inc
• Opal Family Office Winter Forum – New York City, March 6, 2019

• Roth Conference – Laguna Niguel, CA, March 18-19

NORWOOD, MA, March 05, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB: MRMD) a multi-state cannabis operator and hemp CBD product producer, announced today that it will be appearing at two investment conferences in March (same time Crockett was said to be in Maryland).

On Wednesday, March 6, MariMed senior management will attend the Opal Group’s Family Office Winter Forum held at the Marriott Marquis Hotel in Times Square, New York City. It is one of the largest family office events in the U.S. Additionally, MariMed CEO Bob Fireman will participate in a 4:00 PM panel discussion focusing on investing in the cannabis industry.

March 18-19, MariMed senior management will be at the 31st Annual Roth Conference at The Ritz Carlton, Laguna Niguel in Orange County, Calif. This conference is expected to attract close to 550 participating companies and over 4,700 attendees, and will feature presentations from public and private companies in a variety of sectors.

MariMed CEO Bob Fireman noted, “Since the passage of the 2018 Farm Bill, health and wellness products containing hemp-derived CBD are legal nationally. As one of the largest multi-state cannabis operators in the U.S., and as an early investor in high quality, hemp-derived CBD production, we are uniquely well positioned for future growth. MariMed management looks forward to contributing to the investment community’s understanding of this industry and its potential to improve health and wellness across a broad spectrum of conditions.”

About MariMed Inc.

MariMed, Inc. is dedicated to improving health and wellness with the highest quality hemp and cannabis products. The company distributes a full range of branded cannabis products in select states, operates state of the art cannabis facilities in multiple states, and has recently announced the formation of a separate division, MariMed Hemp, focused on the development of industrial hemp-derived CBD products. In late 2018, the Company announced a $30MM investment in Kentucky-based GenCanna, a recognized genetic innovator in industrial hemp. Across its branded products, MariMed is on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed is expanding licensing and distribution to numerous additional markets encompassing thousands of dispensaries.

For additional information, visit www.MariMedAdvisors.com.

https://globenewswire.com/news-release/2019/0...ences.html